Pharmaron Beijing Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 3,285.511 million compared to CNY 2,193.166 million a year ago. Operating income was CNY 669.676 million compared to CNY 536.591 million a year ago. Net income was CNY 564.836 million compared to CNY 478.960 million a year ago. Basic earnings per share from continuing operations was CNY 0.7126 compared to CNY 0.6053 a year ago. Diluted earnings per share from continuing operations was CNY 0.7121 compared to CNY 0.6045 a year ago.